Publication brief · GLP-1 · 2025
Emerging obesity medications may change nutrition's value proposition, freeing the field to focus more clearly on dietary quality, defined health outcomes, and weight-loss maintenance.
The original LinkedIn series
These two historical carousels explain the 2025 Perspective in its original visual language. Part I asks why nutrition's role may change. Part II asks what nutrition can do next.
The series opens by asking how emerging obesity medications might alter nutrition's value proposition.
Use arrow keys, Home or End, swipe, or choose a card below.The argument in one line
This page distills a peer-reviewed Perspective. It separates the paper's context from the authors' proposed reframing and the questions that remain open.
For decades, nutrition science and the food industry have carried an outsized expectation: solve chronic energy imbalance through food choice and behavior. The Perspective argues that this expectation has obscured other contributions that nutrition is better positioned to make.
Emerging obesity medications may change that context. If pharmacology makes energy imbalance more tractable for many people, nutrition can focus more sharply on dietary quality, defined health outcomes, and the distinct challenge of maintaining lost weight.
The story spine
The paper moves from a stubborn systems problem to a narrower, more tractable research and practice agenda. The sequence matters because each claim sets the boundary for the next.
Decades of behavioral and dietary approaches have produced modest and inconsistent effects on long-term body weight. The paper locates that record inside a larger system of physiological, environmental, social, and genetic forces.
Physical activity's public-health value became clearer when the field stopped judging it mainly by weight-loss induction. It remains important for health and can support weight-loss maintenance even when its effect on weight loss is modest.
Emerging obesity medications may make chronic energy imbalance more tractable for many people. The Perspective treats that development as a change in context, not a claim that pharmacology solves obesity or replaces nutrition.
Losing weight and maintaining lost weight are related but distinct physiological challenges. Their determinants overlap only in part, which raises a practical question: why do the two playbooks so often look alike?
If energy balance becomes less dominant, specific dietary properties may become easier to study and act on. Fatty acid profile, sodium, carbohydrate quality, fiber, micronutrients, and adequate protein can move closer to the foreground.
Nutrition science, clinical practice, and product development can invest more deliberately in defined health outcomes while retaining essential roles in maintenance and in care for people who cannot, do not, or no longer use medication.
A tractable priority map
These priorities are examples from the Perspective, not an exhaustive care protocol. Their common feature is a defined nutritional lever tied to a defined health outcome.
Use fatty acid profile and sodium reduction as defined levers for blood-pressure and lipid-related outcomes.
Study carbohydrate quality, fiber, and other specific dietary properties against tractable glycemic and digestive outcomes.
Protect calcium, vitamin D, potassium, and other nutrients that may become harder to obtain when total intake falls.
Prioritize adequate protein and appropriate support for lean tissue during weight loss and weight-loss maintenance.
The evidence boundary
